Philippe Marchand

COO at Samumed

Dr. Marchand is an operations executive and an entrepreneur. Previously, Dr. Marchand was the CIO of Genoptix (a subsidiary of Novartis) where he initially led engineering development and operations. As CIO, Dr. Marchand oversaw the creation of the Diagnostics Laboratory, the subsequent IPO, and the acquisition of Genoptix by Novartis. Following the acquisition of Genoptix, he assumed responsibilities for global IT operations with Novartis Oncology. Earlier in his career, Dr. Marchand founded two San Diego-based technology companies, Celula and Parallel Solutions, where he assumed the role of CTO and President, respectively.

Dr. Marchand received a M.S. (Hons.), a Ph.D., and the Research Habilitation in Electrical Engineering from the Université de Haute Alsace, France and was a Lavoisier post-doctoral fellow at the University of California, San Diego.


  • COO

    Current role